2018 Q1 total revenue records a 6% increase year-over-year Focal One Final Additional Information submitted to FDA early May EDAP to attend American Urological Association congress in San Francisco , May 18-21, 2018 LYON, France , May 14, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the

Receives FDA clearance for novel Focal One device for prostate tissue ablation LYON, France , August 29, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today financial results for the second quarter of 2018 and provided a strategic and

Generated revenue growth of more than 14% as compared to the third quarter of 2017 Continued geographic expansion of Focal One with installations in Brazil and South Korea Since receiving FDA clearance for Focal One in June 2018 , progressed through the lengthy capital equipment sales cycle with

Clinical Results Presented at the Southeastern Section of the American Urological Association Confirms HIFU's Safety, Efficacy and Benefits for Patients' Quality Of Life LYON, FRANCE , AUSTIN, TX -- APRIL 3, 2018 - EDAP TMS (Nasdaq: EDAP) today announced that preliminary results of the first U.S.

LYON, France , May 2, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2018 , after the close of the financial markets on Monday, May 14, 2018 .

Company to host conference call and webcast on Tuesday, April 2 at 8:30am EDT LYON , France, March 21, 2019  -  EDAP TMS SA  (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the fourth quarter and year ended December 31,

LYON, France , July 24, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the second quarter and six months ended June 30, 2018 , before the open of the financial markets on Thursday, August 30, 2018 .

LYON, France , November 6, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter and nine months ended September 30, 2018 , after the close of the financial markets on Wednesday, November 14,

LYON, France , March 14, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the year ended December 31, 2017 , after the close of the financial markets on Tuesday, March 27, 2018 .

LYON , France, November 20, 2018  -  EDAP TMS SA  (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference , taking place November 27-29, 2018 in New York City .